Prostate cancer（PCa） is the most prevalent cancer among male genitourinary tumors and is second only to lung cancer in terms of death rate.The incidence of PCa in China has shown a significant increase in recent years

becoming a major factor threatening men’s health the research and application of PCa tumor markers is the key to early diagnosis of PCa

reducing mortality and improving the quality of patient survival.This article reviews the latest research progress of several prostate cancer-specific antigens

hoping to be a reference for clinicians.